Loading
Latest filing published 26 Sept 2023 for Reata Pharmaceuticals INC. Read the official filing
No signal scores available.
James Warren Huff appears in our data through filings on Reata Pharmaceuticals Inc shares, published by SEC (Form 4). Over a trading history stretching from 3 January 2023 to 26 September 2023, the count stands at 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 26 September 2023, reports a transaction in Reata Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations